|
CQ Treatment failures by Day 28 (adjusted by genotyping), stratified by age group and study site |
||||
| CQ |
No. of treatment failure/Total of Patients (%) [95% CI] |
|||
|
|
||||
| 0.5 – 4 years |
≥ 5 years |
All age |
||
|
|
||||
| Tropical |
Maevatanana |
19/28 (67.9) [49.1–83.0] |
9/24 (37.5) [20.1–57.8] |
28/52 (53.8) [40.3–67.0] |
| Miandrivazo |
10/16 (62.5) [37.6–83.2] |
16/50 (32.0) [20.2–45.8] |
26/66 (39.4) [28.2–51.5] |
|
| Highlands |
Moramanga |
10/26 (38.5) [21.5–57.9] |
3/10 (30.0) [8.3–62.0] |
13/36 (36.1) [21.8–52.6] |
| Tsiroanomandidy |
13/21 (61.9) [40.2–80.5] |
9/17 (52.9) [29.7–75.2] |
22/38 (57.9) [41.9–72.7] |
|
| Sub-desert |
Ejeda |
14/20 (70.0) [47.7–86.8] |
18/30 (60.0) [41.9–76.2] |
32/50 (64.0) [50.1–76.4] |
| Ihosy |
3/20 (15.0) [4.0–35.6] |
8/38 (21.1) [10.3–36.1] |
11/58 (19.0) [10.4–30.6] |
|
|
CQ: Chloroquine. CI: Confidence Interval. Chi-square test for the comparison of two proportions | ||||
Ménard et al. Malaria Journal 2008 7:55 doi:10.1186/1475-2875-7-55 |
||||